Boan Receives FDA IND Clearance for Its CD228-Directed ADC

Boan Biotech today announced that it has received the Study May Proceed Letter from the U.S. Food and Drug Administration (FDA) to proceed with the planned clinical study of the novel investigational ...

VOLUNTARY ANNOUNCEMENT APPROVAL OBTAINED FOR INITIATING CLINICAL TRIALS FOR BA1302 IN THE U.S.

Boan Grants Shaphar Right to Commercialize BA5101 in China

Boan Biotech today announced a strategic partnership with Shanghai Pharmaceutical Co., Ltd. (Shaphar), granting the latter the exclusive right to market and distribute its Dulaglutide Injection (code-...

COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE

Next Day Disclosure Return

Articles of Association

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 5 JUNE 2025, APPOINTMENT OF EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTOR, CHANGES IN THE COMPOSITION OF BOARD COMMITTEES AND AMENDMENTS OF THE ARTICLES OF ASSOCIATION

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025

PLACING OF NEW SHARES UNDER GENERAL MANDATE